Position in LXRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,643,309
-$2,230,453 QoQ
Shares Held
684,713
-72.4% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. LXRX ranks #226 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in LXRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,643,309 | 684,713 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,873,762 | 2,483,182 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,458,321 | 3,007,237 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $476,443 | 352,922 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $380,693 | 400,732 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $963,854 | 2,095,340 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $507,725 | 686,117 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $219,786 | 139,992 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $270,668 | 161,113 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $400,705 | 166,961 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $259,511 | 169,616 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $136,644 | 125,362 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $223,418 | 97,563 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $337,104 | 138,726 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $305,251 | 159,818 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $224,846 | 93,686 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $394,604 | 212,153 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $443,216 | 212,066 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $378,239 | 96,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,114 | 3,974 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,138 | 1,991 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $80,112 | 13,648 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $46,672 | 13,647 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $4,206 | 2,921 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $53,782 | 26,891 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $32,125 | 16,475 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||